Citation: G. Marzio et al., In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies, P NAS US, 98(11), 2001, pp. 6342-6347
Authors:
Verhoef, K
Bilodeau, PS
van Wamel, JLB
Kjems, J
Stoltzfus, CM
Berkhout, B
Citation: K. Verhoef et al., Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site, J VIROLOGY, 75(7), 2001, pp. 3495-3500
Authors:
Verhoef, K
Marzio, G
Hillen, W
Bujard, H
Berkhout, B
Citation: K. Verhoef et al., Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat, J VIROLOGY, 75(2), 2001, pp. 979-987
Authors:
Jeeninga, RE
Hoogenkamp, M
Armand-Ugon, M
de Baar, M
Verhoef, K
Berkhout, B
Citation: Re. Jeeninga et al., Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G, J VIROLOGY, 74(8), 2000, pp. 3740-3751
Citation: K. Verhoef et B. Berkhout, A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus, J VIROLOGY, 73(4), 1999, pp. 2781-2789
Authors:
Berkhout, B
Verhoef, K
van Wamel, JLB
Back, NKT
Citation: B. Berkhout et al., Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains, J VIROLOGY, 73(2), 1999, pp. 1138-1145
Authors:
Verhoef, K
Sanders, RW
Fontaine, V
Kitajima, S
Berkhout, B
Citation: K. Verhoef et al., Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappa B enhancer element into a GABP binding site, J VIROLOGY, 73(2), 1999, pp. 1331-1340